elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43130011-30738D44-B7B9-45D7-A427-4E8C3EAA2B93
Q43130011-30738D44-B7B9-45D7-A427-4E8C3EAA2B93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43130011-30738D44-B7B9-45D7-A427-4E8C3EAA2B93
Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck.
P2860
Q43130011-30738D44-B7B9-45D7-A427-4E8C3EAA2B93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43130011-30738D44-B7B9-45D7-A427-4E8C3EAA2B93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
657efe0e6645ff5556734139bb79caf3d0b88ce0
P2860
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.